Image_1_Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.jpeg by Xuefeng Niu (519266)

“…Panoramic concurrent assessment of BCR repertoires demonstrated isotype switching and a transient but dramatic early IgA expansion. Dominant B cell clonal expansion with decreased diversity occurred following recovery from infection. …”

Example of host noncoding transcripts significantly upregulated or downregulated in infected samples compared to mock infection. by Seth B. Garren (799962)

DataSheet_2_Epigenetic immune monitoring for COVID-19 disease course prognosis.zip by Björn Samans (7254668)

“…In venous blood, we detected relative lymphopenia, neutrophilia, and a decreased lymphocyte-to-neutrophil ratio for COVID-19 patients (n =103) when compared with healthy donors (n = 113). …”

DataSheet_1_Epigenetic immune monitoring for COVID-19 disease course prognosis.docx by Björn Samans (7254668)

“…In venous blood, we detected relative lymphopenia, neutrophilia, and a decreased lymphocyte-to-neutrophil ratio for COVID-19 patients (n =103) when compared with healthy donors (n = 113). …”

DataSheet_2_Epigenetic immune monitoring for COVID-19 disease course prognosis.zip by Björn Samans (7254668)

“…In venous blood, we detected relative lymphopenia, neutrophilia, and a decreased lymphocyte-to-neutrophil ratio for COVID-19 patients (n =103) when compared with healthy donors (n = 113). …”

DataSheet_1_Epigenetic immune monitoring for COVID-19 disease course prognosis.docx by Björn Samans (7254668)

“…In venous blood, we detected relative lymphopenia, neutrophilia, and a decreased lymphocyte-to-neutrophil ratio for COVID-19 patients (n =103) when compared with healthy donors (n = 113). …”

A Survey of the Vegetative Abundance, Diversity and Cover in Grasslands using Quadrat Measurements by Monica Matta (3120636)

Numerical Study of Impurity-Induced Growth Hysteresis on a Growing Crystal Surface by Hitoshi Miura (1515961)

Numerical Study of Impurity-Induced Growth Hysteresis on a Growing Crystal Surface by Hitoshi Miura (1515961)

Gene expression levels of the plasma membrane localized TLRs <i>Tlr1</i>, <i>Tlr2</i>, <i>Tlr4</i>, <i>Tlr5</i>, and <i>Tlr6</i> in different heart failure models of diverse etiolo... by Peter Moritz Becher (192666)

“…In STZ-induced diabetic cardiomyopathy (shown green), a decreased gene expression of <i>Tlr5</i> in comparison to their healthy controls was detected; the remaining plasma membrane localized TLRs displayed no changes in gene expression levels. …”

DataSheet_1_Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients.docx by Anna Julia Pietrobon (9964839)

Supplementary file 4_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Data Sheet 4_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.csv by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Supplementary file 1_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Supplementary file 2_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Supplementary file 3_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.gif by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Data Sheet 3_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.csv by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Data Sheet 1_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.csv by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Data Sheet 2_Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021.csv by Zhijian Huang (1649578)

“…Death rates fell from 15.9 (14.9–16.5)/100,000 to 9.4 (8.5–9.9)/100,000, while DALYs decreased from 485.1 (462.9–507.0)/100,000 to 277.4 (260.1–294.8)/100,000 over the same period. …”

Supplementary Material for: Effects of a DPP4 Inhibitor on Progression of NASH-related HCC and the p62/ Keap1/Nrf2-Pentose Phosphate Pathway in a Mouse Model by Kawaguchi T. (5713799)

“…Metabolome analysis revealed that DPP4i significantly increased 6-phosphogluconic acid and ribose 5-phosphate levels and decreased the AMP-to-adenine and GMP-to-guanine ratios (AMP-to-adenine ratio 0.7 ± 0.2 vs. 2.0 ± 1.2, <i>p</i> < 0.01; GMP-to-guanine ratio 0.6 ± 0.3 vs. 1.5 ± 0.7, <i>p</i> < 0.01). …”